8-K 1 f8k_081903.txt CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ----------------------------- Date of Report (Date of earliest event reported): August 18, 2003 Orthofix International N.V. (Exact name of Registrant as specified in its charter) Netherlands Antilles 0-19961 N/A (State or other jurisdiction Commission (I.R.S. Employer of incorporation) File Number Identification Number) ----------------------------- 7 Abraham de Veerstraat Curacao Netherlands Antilles 011-59-99-465-8525 (Address of principal executive offices and telephone number, including area code) ----------------------------- Item 5. Other Events and Regulation FD Disclosure. ----------------------------------------- On August 18, 2003, Orthofix International N.V. ("Orthofix") issued a press release announcing the settlement of a government investigation regarding off-label use of its external bone growth stimulator. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. Exhibit ------- 99.1 Press release of Orthofix International N.V. dated August 18, 2003 Signature Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 19, 2003 ORTHOFIX INTERNATIONAL N.V. By: /s/ Thomas Hein ------------------------------ Name: Thomas Hein Title: Chief Financial Officer